1030-1032 Stuyvesant Ave Irvington, NJ 07111
This exceptional investment opportunity presents a prime office building situated at 1030-1032 Stuyvesant Avenue in Irvington, New Jersey. The property is listed at $598,900 and offers significant potential for growth and return. While the exact square footage is not currently specified, the building's location in a desirable area of Irvington makes it an attractive prospect for a variety of businesses. The property sits on a lot with no acreage specified, suggesting a compact and potentially easily managed footprint. The address, 1030-1032 Stuyvesant Avenue, indicates a potentially larger building, suitable for multiple tenants or a single large occupant. Given the price point and location, this property is ideal for investors seeking a strong foothold in the New Jersey commercial real estate market. Further due diligence is recommended to ascertain the precise square footage and internal layout of the building, as well as the zoning regulations and potential for future development. This property represents a compelling opportunity for those seeking a profitable investment in a thriving New Jersey community. The absence of specified square footage and lot size underscores the need for a thorough on-site inspection to fully assess the property's potential. Interested parties are encouraged to conduct their own independent investigation to confirm all details and determine the suitability of this property for their specific needs.
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendComparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.